BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19432118)

  • 1. [Osteoporosis treatment for fracture prevention in elderly].
    Takeuchi Y
    Nihon Ronen Igakkai Zasshi; 2024; 61(2):93-102. PubMed ID: 38839326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin A - discovery, metabolism, receptor signaling and effects on bone mass and fracture susceptibility.
    Lerner UH
    Front Endocrinol (Lausanne); 2024; 15():1298851. PubMed ID: 38711977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potassium: A Frontier in Osteoporosis.
    Singh W; Kushwaha P
    Horm Metab Res; 2024 May; 56(5):329-340. PubMed ID: 38346690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Vitamin D 3 Supplementation on Incident Fractures by eGFR in VITAL.
    Hsu S; Zelnick LR; Buring JE; Chou SH; Cook NR; D'Agostino D; Hoofnagle AN; LeBoff MS; Lee IM; Limonte CP; Sesso HD; Manson JE; de Boer IH
    Clin J Am Soc Nephrol; 2024 May; 19(5):638-640. PubMed ID: 38265769
    [No Abstract]   [Full Text] [Related]  

  • 5. Spontaneous Insufficiency Fractures.
    Brennan M; O'Shea PM; O'Keeffe ST; Mulkerrin EC
    J Nutr Health Aging; 2019; 23(8):758-760. PubMed ID: 31560035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction to: Determination of the combined effects of asian herbal medicine with calcium and/or vitamin D supplements on bone mineral density in primary osteoporosis: A systematic review and meta-analysis.
    Park HJ; Kim MG; Yoo YS; Lee B; Choi YJ; Son CG; Lee EJ
    Osteoporos Int; 2024 Jul; 35(7):1311. PubMed ID: 38512462
    [No Abstract]   [Full Text] [Related]  

  • 7. Off Label Antiviral Therapeutics for Henipaviruses: New Light Through Old Windows.
    Aljofan M; Lo MK; Rota PA; Michalski WP; Mungall BA
    J Antivir Antiretrovir; 2010 Jan; 2(1):1-10. PubMed ID: 20668647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vitamin D and calcium for the treatment of osteoporosis].
    Inoue D
    Nihon Rinsho; 2009 May; 67(5):967-74. PubMed ID: 19432118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evidence for efficacy of active vitamin D3 as an anti-osteoporotic drug].
    Inoue D
    Clin Calcium; 2008 Oct; 18(10):1469-75. PubMed ID: 18830044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Latest evidence on the suppressive effect of active vitamin D3 on fractures].
    Yamauchi M; Sugimoto T
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():396-401. PubMed ID: 18161139
    [No Abstract]   [Full Text] [Related]  

  • 11. [Frontiers in vitamin D; basic Research and clinical application. Effect of active vitamin D3 on osteoporosis].
    Yamauchi M; Sugimoto T
    Clin Calcium; 2011 Nov; 21(11):17-24. PubMed ID: 22040817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vitamine D in patients with osteoporosis: sufficient or necessary?].
    Ferrari S
    Rev Med Suisse; 2007 Jun; 3(115):1515-6, 1518-20. PubMed ID: 17682795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of vitamin D on bone mineral density; bone strength and fracture prevention].
    Okuizumi H; Harada A
    Clin Calcium; 2006 Jul; 16(7):1115-21. PubMed ID: 16816470
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.